Need assistance?
We’re here for you

NovoCare® is here to help patients like you access and afford their medications. This site is available 24/7, and we offer live support through the phone numbers listed below.

Further down on this page, you’ll also find answers to frequently asked questions.

Need assistance?
We’re here for you

NovoCare® is here to help patients like you access and afford their medications. This site is available 24/7, and we offer live support through the phone numbers listed below.

Further down on this page, you’ll also find answers to frequently asked questions.

Diabetes

Monday-Friday, 8:00 am-11:00 pm
Saturday, 11:00 am-7:00 pm
Eastern Standard Time

Obesity

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Primary hyperoxaluria type 1 (PH1)

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Growth Hormone

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Hemophilia

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Report a side effect or issue with your medication

Please submit a form online or by calling 800‑727‑6500

Frequently Asked Questions

Frequently Asked Questions 

Medicines are incredibly expensive to research and develop in general. It can take billions of dollars to bring a single safe and effective medicine to market.

Your insurance situation also factors into the price you pay for medicine. Novo Nordisk has teams of people negotiating with insurers to ensure better coverage for our products. Ultimately, though, it’s up to the insurer to decide whether to cover a product and the level of coverage. Additionally, your insurance provider will determine whether you pay a flat fee, called a “copay,” or a percentage of the total cost, called “coinsurance."

To find out if your insurance covers your medicine, make a selection below.

Diabetes medicines
Fiasp® (insulin aspart) injection 100 U/mL
Levemir® (insulin detemir) injection 100 U/mL
NovoLog® (insulin aspart) injection 100 U/mL
NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg
Tresiba® (insulin degludec) injection 100 U/mL or 200 U/mL
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg
Xultophy® 100/3.6 (insulin degludec and liraglutide) injection 100 U/mL and 3.6 mg/mL

Obesity medicines
Saxenda® (liraglutide) injection 3 mg
Wegovy® (semaglutide) injection 2.4 mg

Primary hyperoxaluria type 1 (PH1) medicine
For coverage information, connect with a NovoCare® representative at 844‑906‑5099

Growth-related disorders medicines
For coverage information about Novo Nordisk growth-related disorders medicines, connect with a NovoCare® representative at 888‑668‑6444

Hemophilia and rare bleeding disorders medicines
For coverage information about Novo Nordisk hemophilia and rare bleeding disorders medicines, connect with a NovoCare® representative at 844‑668‑6732

There are limits to the ways in which Novo Nordisk can support patients with government-funded insurance.  

For patients with diabetes, please call 844-Novo4Me (844-668-6463) to discuss other options that may be available.

For patients with obesity, growth-related disorders, or hemophilia and bleeding disorders, please contact your prescription insurance provider to discuss options.

We have assistance programs and savings offers which may help reduce the cost of your insulin or provide it at no cost, depending on your situation.

If you have questions about your copay offer, please contact the following numbers for your medicine:

Diabetes medicines
Fiasp® (insulin aspart) injection 100 U/mL—833-992-3299
NovoLog® (insulin aspart) injection 100 U/mL—833-992-3299
NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL—833-992-3299
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg—877-304-6855
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg—877-304-6855
Tresiba® (insulin degludec) injection 100 U/mL or 200 U/mL—833-992-3299

Other products
ZEGALOGUE® (dasiglucagon) injection 0.6 mg/0.6 mL—833-992-3299

Obesity medicines
Wegovy® (semaglutide) injection 2.4 mg—888-793-1218

Primary hyperoxaluria type 1 (PH1) medicine
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg—844-906-5099

Growth-related disorders medicines
Norditropin® (somatropin) injection 5 mg, 10 mg, 15 mg, 30 mg pens—866‑316‑2404
Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, 15 mg pens—866-316-2404

Hemophilia and rare bleeding disorders medicines
For all hemophilia and rare bleeding disorder medications, please call 844‑668‑6732